Ronald Muhlenkamp
Muhlenkamp & Co
Muhlenkamp & Co Portfolio 13F
Ronald Muhlenkamp Holdings Activity
- Portfolio value:
- $186.97M≈ (-$42M≈)
- Previous value:
- $228.82M≈
- # of changes:
- 37
- New positions:
- 2
- Reported for:
- 30 Jun 2020 (Q2)
- Latest filing date:
- 20 Aug 2020
Muhlenkamp & Co has disclosed a total of 37 changes to the portfolio in the (2020 Q2) SEC report(s): increased the number of shares of 14, bought 2 totally new, decreased the number of shares of 13 and completely sold out 8 position(s).
What stocks did Ronald Muhlenkamp buy in 2020 Q2?
During 2020 Q2 Ronald Muhlenkamp has bought 16 securities out of which top 5 purchases (by % change to portfolio) were (DOW) Dow Inc (added shares +50.62%), (MTH) Meritage Corp (added shares +0.36%), (AVGO) Broadcom Inc (added shares +0.15%), (BMY) Bristol-Myers Squibb Company (added shares +0.04%) and (UNH) UnitedHealth Group Incorporated (added shares +131.91%).
In the 2020 Q2 report(s) the following changes have been made to the top investments: (MSFT) Microsoft Corp (reduced shares -18.82%), (AAPL) Apple Inc (reduced shares -33.58%), (GLD) SPDR Gold Shares (reduced shares -16.19%), (MCK) McKesson Corp (reduced shares -0.00%) and (MCHP) Microchip Technology Inc (reduced shares -0.08%).
37 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
MasTec Inc
|
new
|
$44.87
|
+479.38%($259.98)
|
2.22%
|
2020 Q2
|
≈ 0.25 years
|
||||
|
|
NMI Holdings Inc
|
new
|
$16.08
|
+176.31%($44.43)
|
2.77%
|
2020 Q2
|
≈ 0.25 years
|
||||
|
|
UnitedHealth Group Incorporated
|
+131.91%
|
$294.96
|
+41.17%($416.40)
|
3.79%
|
2016 Q1
|
≈ 4.00 years
|
||||
|
|
Bread Financial Holdings, Inc
|
+81.66%
|
$45.12
|
+146.88%($111.40)
|
2.97%
|
2013 Q2 or earlier
|
≈ 6.75+ years
|
||||
|
|
TENNECO INC, CL-A
|
+51.01%
|
$7.56
|
|
2.28%
|
2019 Q4
|
≈ 0.50 years
|
||||
|
|
Dow Inc
|
+50.62%
|
$40.76
|
-25.92%($30.20)
|
4.89%
|
2019 Q2
|
≈ 1.00 year
|
||||
|
|
Gilead Sciences Inc
|
+25.18%
|
$76.94
|
+68.26%($129.46)
|
2.03%
|
2013 Q2 or earlier
|
≈ 6.75+ years
|
||||
|
|
Westinghouse Air Brake Technologies Corp
|
+1.38%
|
$57.57
|
+413.12%($295.39)
|
1.64%
|
2019 Q1
|
≈ 1.25 years
|
||||
|
|
Meritage Corp
|
+0.36%
|
$76.12
|
-5.80%($71.70)
|
4.81%
|
2019 Q2
|
≈ 1.00 year
|
||||
|
|
Biogen Inc
|
+0.35%
|
$267.57
|
-25.04%($200.58)
|
2.55%
|
2016 Q1
|
≈ 4.00 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.